Concepedia

Cindy Jacobs

CJ

Statistics

Publications

40

Citations

2.2K

H-Index

23

Active since

1987

Affiliations

OncoGenex Pharmaceuticals (United States)(Current)

BC Cancer Agency

Research & Development Corporation

University of Washington

Fred Hutch Cancer Center

Cindy Jacobs is an author at OncoGenex Pharmaceuticals (United States) specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

1987–2023

40

Publications

40

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial

A. Keith Stewart, Robert Vescio, Gary J. Schiller et al. · Journal of Clinical Oncology · 2001 · 198 citations

Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running

Hans Sprenger, Cindy Jacobs, Marianne Nain et al. · Clinical Immunology and Immunopathology · 1992 · 195 citations

, , +11

Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor

Cindy Jacobs, Paul E. Baker, E R Roux et al. · The Journal of Immunology · 1991 · 182 citations · Full text

Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.

Robert Vescio, Gary J. Schiller, A. Keith Stewart et al. · PubMed · 1999 · 172 citations

Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo

Tomoe Sato, M B Widmer, F D Finkelman et al. · The Journal of Immunology · 1993 · 144 citations

1–5 of 40